πŸ“‹ Family Issues/Abortion/Adoption (FAM)

Federal lobbying activity for the family issues/abortion/adoption issue area

πŸ€–

AI Overview

Family Issues/Abortion/Adoption (FAM) has attracted $23.4M in lobbying spending across 2,531 filings. This issue area sees targeted lobbying from organizations with specific policy interests.

$23.4M
Total Spending
2,531
Total Filings
$34.5M
Estimated Spending

Spending by Year

Top Clients

Top Lobbying Firms

Sample Lobbying Descriptions

β€’Controlled Substance act improvements. Opioid overdose death reduction. Alprazolam rescheduling.

β€’Veterans administration (structure, benefits, services, and quality of care) Family code (UCCJEA) Federal enforcement of parental rights. Veteran suicide epidemic (root causes, actions, programs, ac

β€’U.S. Refugee Admissions Program Action Plan for Children in Adversity Adoption Foster Care

β€’H.R.3354 and S.1771/final FY2018 LHHS ED appropriation bill re: ESSA Title IV, Part A, Title II Part A, and programs to prevent child sexual abuse. Issues related to prevention of child sexual abuse w

β€’H.R.3354 and S.1662/final FY 2018 CJS appropriation bill re: judicial training and juvenile justice programs H.R.3354 and S.1771/final FY2018 LHHS appropriation bill re: Court Improvement Program S.8

β€’Federal Grant Appliations

β€’Advocating for protections for victims of domestic and dating violence.

β€’Every Child Deserves A Family Act HR2028, S1382. Lobbied in support of prohibiting adoption or foster care entities that receive federal assistance from using sexual orientation, gender identity or ma

β€’H.R.947 & S.337 Family Medical & Insurance Leave Act H.R.1516 & S.636 Healthy Families Act H.R.2942 & S.1386 Schedules That Work Act

β€’Oppose any effort to exclude Planned Parenthood health centers from participating in federal health programs. Support a strong national paid family and medical leave policy. Oppose H.R. 36, the Pain-C

Related Analysis

Related Investigations

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.